Enviar pesquisa
Carregar
JCO_Editorial_Nov2011
•
1 gostou
•
491 visualizações
O
Oregon Health & Science University
Seguir
Saúde e medicina
Negócios
Denunciar
Compartilhar
Denunciar
Compartilhar
1 de 3
Baixar agora
Baixar para ler offline
Recomendados
JCO study_Wang_Nov 2011
JCO study_Wang_Nov 2011
Oregon Health & Science University
Lafposter2011 (2)
Lafposter2011 (2)
Oregon Health & Science University
Jco 2010-rizzo-jco.2010.29.2201
Jco 2010-rizzo-jco.2010.29.2201
Clinica de imagenes
2010 Oncology Nursing Society Congress
2010 Oncology Nursing Society Congress
Clinica de imagenes
ANZUP1 (dragged)
ANZUP1 (dragged)
Todd Manning
Managing central venous access devices in cancer patients a practice guidelin...
Managing central venous access devices in cancer patients a practice guidelin...
Clinica de imagenes
Treatment of Brain Metastases Using the Current Predictive Models: Is the Pro...
Treatment of Brain Metastases Using the Current Predictive Models: Is the Pro...
CrimsonpublishersCancer
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
CrimsonpublishersCancer
Recomendados
JCO study_Wang_Nov 2011
JCO study_Wang_Nov 2011
Oregon Health & Science University
Lafposter2011 (2)
Lafposter2011 (2)
Oregon Health & Science University
Jco 2010-rizzo-jco.2010.29.2201
Jco 2010-rizzo-jco.2010.29.2201
Clinica de imagenes
2010 Oncology Nursing Society Congress
2010 Oncology Nursing Society Congress
Clinica de imagenes
ANZUP1 (dragged)
ANZUP1 (dragged)
Todd Manning
Managing central venous access devices in cancer patients a practice guidelin...
Managing central venous access devices in cancer patients a practice guidelin...
Clinica de imagenes
Treatment of Brain Metastases Using the Current Predictive Models: Is the Pro...
Treatment of Brain Metastases Using the Current Predictive Models: Is the Pro...
CrimsonpublishersCancer
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
CrimsonpublishersCancer
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer Medicine
HCA Healthcare UK
Association between genomic recurrence risk and well-being among breast cance...
Association between genomic recurrence risk and well-being among breast cance...
Enrique Moreno Gonzalez
Epidemological methods
Epidemological methods
Kundan Singh
research poster - karishma patel
research poster - karishma patel
karishma patel
Perceived benefits and barriers to exercise for recently treated patients wit...
Perceived benefits and barriers to exercise for recently treated patients wit...
Enrique Moreno Gonzalez
The impact of minimally invasive surgery on complex drg assignments
The impact of minimally invasive surgery on complex drg assignments
Vojislav Valcic MBA
Primary Surgery vs Chemoradiotherapy for Oropahryngeal Cancer
Primary Surgery vs Chemoradiotherapy for Oropahryngeal Cancer
Gloria Ate
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015
Nicole Proulx
neuroblastoma
neuroblastoma
danmal123
Discuss the principles guiding the use of radiotherapy in surgery
Discuss the principles guiding the use of radiotherapy in surgery
Abdullahi Sanusi
Nrclinonc.2011.81
Nrclinonc.2011.81
Elsa von Licy
Clinical Trials 101
Clinical Trials 101
Melanoma Research Foundation
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...
Enrique Moreno Gonzalez
Palliative radiotherapy in bone metastasis
Palliative radiotherapy in bone metastasis
Ganavian Hospital
The American Association for Thoracic Surgery guidelines for lung cancer scre...
The American Association for Thoracic Surgery guidelines for lung cancer scre...
Grutórax Cirurgia Torácica e Broncoscopia
kellygarcia.positionpaperdraft
kellygarcia.positionpaperdraft
Kelly Garcia
Whole body ct adult versus ped centers (iep)
Whole body ct adult versus ped centers (iep)
bahlinnm
The role of traf3 and cyld mutationin the etiology of human papillomavirus dr...
The role of traf3 and cyld mutationin the etiology of human papillomavirus dr...
TÀI LIỆU NGÀNH MAY
Limiting the risks
Limiting the risks
Preston Ray
Knight funding opportunities announcement 2011
Knight funding opportunities announcement 2011
Oregon Health & Science University
Croet zarbl 09 22_11 flyer
Croet zarbl 09 22_11 flyer
Oregon Health & Science University
Knight funding opportunities announcement 2011
Knight funding opportunities announcement 2011
Oregon Health & Science University
Mais conteúdo relacionado
Mais procurados
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer Medicine
HCA Healthcare UK
Association between genomic recurrence risk and well-being among breast cance...
Association between genomic recurrence risk and well-being among breast cance...
Enrique Moreno Gonzalez
Epidemological methods
Epidemological methods
Kundan Singh
research poster - karishma patel
research poster - karishma patel
karishma patel
Perceived benefits and barriers to exercise for recently treated patients wit...
Perceived benefits and barriers to exercise for recently treated patients wit...
Enrique Moreno Gonzalez
The impact of minimally invasive surgery on complex drg assignments
The impact of minimally invasive surgery on complex drg assignments
Vojislav Valcic MBA
Primary Surgery vs Chemoradiotherapy for Oropahryngeal Cancer
Primary Surgery vs Chemoradiotherapy for Oropahryngeal Cancer
Gloria Ate
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015
Nicole Proulx
neuroblastoma
neuroblastoma
danmal123
Discuss the principles guiding the use of radiotherapy in surgery
Discuss the principles guiding the use of radiotherapy in surgery
Abdullahi Sanusi
Nrclinonc.2011.81
Nrclinonc.2011.81
Elsa von Licy
Clinical Trials 101
Clinical Trials 101
Melanoma Research Foundation
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...
Enrique Moreno Gonzalez
Palliative radiotherapy in bone metastasis
Palliative radiotherapy in bone metastasis
Ganavian Hospital
The American Association for Thoracic Surgery guidelines for lung cancer scre...
The American Association for Thoracic Surgery guidelines for lung cancer scre...
Grutórax Cirurgia Torácica e Broncoscopia
kellygarcia.positionpaperdraft
kellygarcia.positionpaperdraft
Kelly Garcia
Whole body ct adult versus ped centers (iep)
Whole body ct adult versus ped centers (iep)
bahlinnm
The role of traf3 and cyld mutationin the etiology of human papillomavirus dr...
The role of traf3 and cyld mutationin the etiology of human papillomavirus dr...
TÀI LIỆU NGÀNH MAY
Limiting the risks
Limiting the risks
Preston Ray
Mais procurados
(19)
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer Medicine
Association between genomic recurrence risk and well-being among breast cance...
Association between genomic recurrence risk and well-being among breast cance...
Epidemological methods
Epidemological methods
research poster - karishma patel
research poster - karishma patel
Perceived benefits and barriers to exercise for recently treated patients wit...
Perceived benefits and barriers to exercise for recently treated patients wit...
The impact of minimally invasive surgery on complex drg assignments
The impact of minimally invasive surgery on complex drg assignments
Primary Surgery vs Chemoradiotherapy for Oropahryngeal Cancer
Primary Surgery vs Chemoradiotherapy for Oropahryngeal Cancer
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015
neuroblastoma
neuroblastoma
Discuss the principles guiding the use of radiotherapy in surgery
Discuss the principles guiding the use of radiotherapy in surgery
Nrclinonc.2011.81
Nrclinonc.2011.81
Clinical Trials 101
Clinical Trials 101
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...
Palliative radiotherapy in bone metastasis
Palliative radiotherapy in bone metastasis
The American Association for Thoracic Surgery guidelines for lung cancer scre...
The American Association for Thoracic Surgery guidelines for lung cancer scre...
kellygarcia.positionpaperdraft
kellygarcia.positionpaperdraft
Whole body ct adult versus ped centers (iep)
Whole body ct adult versus ped centers (iep)
The role of traf3 and cyld mutationin the etiology of human papillomavirus dr...
The role of traf3 and cyld mutationin the etiology of human papillomavirus dr...
Limiting the risks
Limiting the risks
Destaque
Knight funding opportunities announcement 2011
Knight funding opportunities announcement 2011
Oregon Health & Science University
Croet zarbl 09 22_11 flyer
Croet zarbl 09 22_11 flyer
Oregon Health & Science University
Knight funding opportunities announcement 2011
Knight funding opportunities announcement 2011
Oregon Health & Science University
Yaa abastracts
Yaa abastracts
Oregon Health & Science University
Survival lags for adolescents, young adults with cancer
Survival lags for adolescents, young adults with cancer
Oregon Health & Science University
Senology Newsletter - June 4, 2013
Senology Newsletter - June 4, 2013
Senology.org
Knight billboard released spring 2011
Knight billboard released spring 2011
Oregon Health & Science University
Knight Seminar Series 11/15/11
Knight Seminar Series 11/15/11
Oregon Health & Science University
Ava roasteria event postcard 12 8
Ava roasteria event postcard 12 8
Oregon Health & Science University
Destaque
(9)
Knight funding opportunities announcement 2011
Knight funding opportunities announcement 2011
Croet zarbl 09 22_11 flyer
Croet zarbl 09 22_11 flyer
Knight funding opportunities announcement 2011
Knight funding opportunities announcement 2011
Yaa abastracts
Yaa abastracts
Survival lags for adolescents, young adults with cancer
Survival lags for adolescents, young adults with cancer
Senology Newsletter - June 4, 2013
Senology Newsletter - June 4, 2013
Knight billboard released spring 2011
Knight billboard released spring 2011
Knight Seminar Series 11/15/11
Knight Seminar Series 11/15/11
Ava roasteria event postcard 12 8
Ava roasteria event postcard 12 8
Semelhante a JCO_Editorial_Nov2011
Anjali_Ganguly_Siemens_2014
Anjali_Ganguly_Siemens_2014
Anjali Ganguly
Annotation Editorial
Annotation Editorial
AbhishekPuri27
[ASGO 2019] Artificial Intelligence in Medicine
[ASGO 2019] Artificial Intelligence in Medicine
Yoon Sup Choi
E-book Thesis Sara Carvalho
E-book Thesis Sara Carvalho
Sara Carvalho
Clinical oncology-can-observational-research-impact-clinical-decision-making
Clinical oncology-can-observational-research-impact-clinical-decision-making
smithjgrace
Clinical trials article
Clinical trials article
Cancer Treatment Options and Management Inc.
Machine Learning Ppt.pptx
Machine Learning Ppt.pptx
AbdullahShafiq25
Molecular Testing Supplement (Final)
Molecular Testing Supplement (Final)
Marianne Dailey
How is machine learning significant to computational pathology in the pharmac...
How is machine learning significant to computational pathology in the pharmac...
Pubrica
Dalton
Dalton
The Ohio State University Wexner Medical Center
Dalton presentation
Dalton presentation
The Ohio State University Wexner Medical Center
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
Warren Kibbe
PancreaticCancerFinalPaper
PancreaticCancerFinalPaper
Vikram Babu
2016-Crawford-BMC Pulm Med published
2016-Crawford-BMC Pulm Med published
Ji-Youn Yeo
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
Warren Kibbe
main.pdf
main.pdf
anandafebrianiaulia1
scopus database journal
scopus database journal
chaitanya451336
journals to publish paper
journals to publish paper
chaitanya451336
published research
published research
chaitanya451336
journal research paper
journal research paper
chaitanya451336
Semelhante a JCO_Editorial_Nov2011
(20)
Anjali_Ganguly_Siemens_2014
Anjali_Ganguly_Siemens_2014
Annotation Editorial
Annotation Editorial
[ASGO 2019] Artificial Intelligence in Medicine
[ASGO 2019] Artificial Intelligence in Medicine
E-book Thesis Sara Carvalho
E-book Thesis Sara Carvalho
Clinical oncology-can-observational-research-impact-clinical-decision-making
Clinical oncology-can-observational-research-impact-clinical-decision-making
Clinical trials article
Clinical trials article
Machine Learning Ppt.pptx
Machine Learning Ppt.pptx
Molecular Testing Supplement (Final)
Molecular Testing Supplement (Final)
How is machine learning significant to computational pathology in the pharmac...
How is machine learning significant to computational pathology in the pharmac...
Dalton
Dalton
Dalton presentation
Dalton presentation
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
PancreaticCancerFinalPaper
PancreaticCancerFinalPaper
2016-Crawford-BMC Pulm Med published
2016-Crawford-BMC Pulm Med published
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
main.pdf
main.pdf
scopus database journal
scopus database journal
journals to publish paper
journals to publish paper
published research
published research
journal research paper
journal research paper
Mais de Oregon Health & Science University
Celebrate the Knight
Celebrate the Knight
Oregon Health & Science University
Ohsu pain day2012 schedule
Ohsu pain day2012 schedule
Oregon Health & Science University
2011 grant-and-award-booklet web
2011 grant-and-award-booklet web
Oregon Health & Science University
DCH knight flier olwin cme 121311
DCH knight flier olwin cme 121311
Oregon Health & Science University
Blasdel GoldenRoseNov2011
Blasdel GoldenRoseNov2011
Oregon Health & Science University
Romesburg GoldenROSE October2011
Romesburg GoldenROSE October2011
Oregon Health & Science University
RadMed Chitapanarux-2011nov14
RadMed Chitapanarux-2011nov14
Oregon Health & Science University
Sue's poster siop
Sue's poster siop
Oregon Health & Science University
Siop poster ernesto-1
Siop poster ernesto-1
Oregon Health & Science University
Siop poster aya fellowship-1
Siop poster aya fellowship-1
Oregon Health & Science University
Peter Adamson Grand Rounds
Peter Adamson Grand Rounds
Oregon Health & Science University
Knight Seminar Series 10/18/11
Knight Seminar Series 10/18/11
Oregon Health & Science University
Baker Memorial Lecture 2011
Baker Memorial Lecture 2011
Oregon Health & Science University
Knight Seminar Series 2011-12 Schedule
Knight Seminar Series 2011-12 Schedule
Oregon Health & Science University
Knight Seminar Series Spellman
Knight Seminar Series Spellman
Oregon Health & Science University
2011 prostate cancer conference
2011 prostate cancer conference
Oregon Health & Science University
Howard scott gr rounds flyer 102011
Howard scott gr rounds flyer 102011
Oregon Health & Science University
2011 AACR CancerProgressReport_text_web
2011 AACR CancerProgressReport_text_web
Oregon Health & Science University
Shoc golf poster_2011
Shoc golf poster_2011
Oregon Health & Science University
Fondo 2011 event-guide
Fondo 2011 event-guide
Oregon Health & Science University
Mais de Oregon Health & Science University
(20)
Celebrate the Knight
Celebrate the Knight
Ohsu pain day2012 schedule
Ohsu pain day2012 schedule
2011 grant-and-award-booklet web
2011 grant-and-award-booklet web
DCH knight flier olwin cme 121311
DCH knight flier olwin cme 121311
Blasdel GoldenRoseNov2011
Blasdel GoldenRoseNov2011
Romesburg GoldenROSE October2011
Romesburg GoldenROSE October2011
RadMed Chitapanarux-2011nov14
RadMed Chitapanarux-2011nov14
Sue's poster siop
Sue's poster siop
Siop poster ernesto-1
Siop poster ernesto-1
Siop poster aya fellowship-1
Siop poster aya fellowship-1
Peter Adamson Grand Rounds
Peter Adamson Grand Rounds
Knight Seminar Series 10/18/11
Knight Seminar Series 10/18/11
Baker Memorial Lecture 2011
Baker Memorial Lecture 2011
Knight Seminar Series 2011-12 Schedule
Knight Seminar Series 2011-12 Schedule
Knight Seminar Series Spellman
Knight Seminar Series Spellman
2011 prostate cancer conference
2011 prostate cancer conference
Howard scott gr rounds flyer 102011
Howard scott gr rounds flyer 102011
2011 AACR CancerProgressReport_text_web
2011 AACR CancerProgressReport_text_web
Shoc golf poster_2011
Shoc golf poster_2011
Fondo 2011 event-guide
Fondo 2011 event-guide
Último
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
narwatsonia7
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Dipal Arora
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
aditipandeya
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
discovermytutordmt
Call Girls Gwalior Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Dipal Arora
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
TANUJA PANDEY
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
aartirawatdelhi
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
astropune
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Call Girls in Nagpur High Profile
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Dipal Arora
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
vidya singh
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
perfect solution
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
parulsinha
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
narwatsonia7
Último
(20)
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Call Girls Gwalior Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
JCO_Editorial_Nov2011
1.
Published Ahead of
Print on November 7, 2011 as 10.1200/JCO.2011.37.8604 The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2011.37.8604 JOURNAL OF CLINICAL ONCOLOGY E D I T O R I A L S When a Decision Must Be Made: Role of Computer Modeling in Clinical Cancer Research Rebecca A. Miksad, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA See accompanying article doi: 10.1200/JCO.2010.33.8020 Every day, multidisciplinary oncology teams make dozens of treat- quantitative, individualized survival predictions on the basis of the ment decisions that may have a tremendous impact on a patient’s experience of more than 1,100 patients with resected gallbladder can- survival and quality of life. Made with the best of intentions, these cer in the Surveillance, Epidemiology, and End Results–Medicare decisions are informed by basic science and clinical research findings, linked databases. Although one must acknowledge that models that clinical experience, and health policy. All too often, results from the are based on health claims data of the type found in the Surveil- gold standard of clinical trial research, a randomized controlled trial lance, Epidemiology, and End Results–Medicare database may lack (RCT), that fit the specific details of the patient’s situation are not important clinical variables, and that models that are based on available to guide these decisions. observational data may reflect selection biases, imperfect informa- Although this data gap occurs at times for all cancers, it is a tion is sometimes better than no information at all. In addition to constant limitation for less common and biologically heterogeneous addressing critiques of a previous model of adjuvant radiation for diseases. For these cancers, such as those of the biliary tract, practical gallbladder cancer, the current chemoradiotherapy prediction model time and expense limitations restrict the number and combinations of provides concrete adjuvant chemoradiotherapy survival benefit esti- therapeutic strategies evaluated, the follow-up duration, and the pop- mates on the basis of patient characteristics.26-29 The Internet-based ulations studied in RCTs.1 And even in the most common cancers, the nomogram that is built on these results provides an interactive tool costly failure of multiple trials that involve thousands of patients to that may help patients, clinicians, and policy makers to make more move cancer care forward has raised the need for alternate re- informed, real-time decisions.30 search paradigms.2-9 Although additional research would be needed to validate the Enter computer modeling as a method to bridge current predictions of the gallbladder cancer adjuvant chemoradiotherapy knowledge gaps and to advance cancer clinical care and research. model described by Wang et al,21 examples in the literature demon- When performed correctly—rigorously developed, calibrated, and strate the potential power of computer modeling, especially compre- validated— computer modeling can maximize the information hensive microsimulation models such as the Lung Cancer Policy that is gained from current clinical, basic science, and epidemio- Model (LCPM).17 The LCPM was initiated a decade before the recent logic research efforts to facilitate informed clinical and health publication of the National Lung Screening Trial (NLST) results. policy decisions.10 This power stems from the ability of computer Nonetheless, in contrast to two large previous clinical studies with models to produce novel comparative effectiveness findings, extend trial results to longer time horizons, expand study findings to new widely divergent findings for computed tomography (CT) screening populations, and refine expected outcomes. Last, but not least, com- of individuals at high risk for lung cancer, the previously published puter models may also help differentiate between those scientific and LCPM results are remarkably consistent with the current NLST find- clinical questions for which an RCT would be preferred but is not vital ings: a 6.7% reduction in all-cause mortality in the clinical trial of three for decision making, and those questions for which the expense, time, annual CT screenings and a 4% reduction in all-cause mortality at 6 and patient effort of an RCT is absolutely required to improve out- years in the LCPM analysis of five annual CT screenings.17,20,31,33-37 comes and to guide treatment and policy decisions.11-20 This consistency in the magnitude of benefit is not a coincidence but In the article that accompanies this editorial, Wang et al21 used rather is the result of a comprehensive microsimulation model of lung survival model techniques to predict the benefit of adjuvant chemo- cancer development, progression, detection, treatment, and survival therapy and chemoradiotherapy for patients with resected gallbladder that accounts for competing mortality risks related to smoking and cancer. Although the prognosis for these patients is usually grim and benign nodules and predicts the stage-shift effect of screening. The the need for an effective treatment is great, there is a paucity of pub- LCPM was extensively calibrated and validated with data from a vari- lished information to guide adjuvant therapy choices.22-25 However, ety of sources. Simulating the NLST trial design and participants will despite this data void, clinicians and policy makers still need to make provide an additional opportunity to validate the precision and accu- the best decisions possible for current patients. racy of model predictions. A model like the LCPM does not replace As an alternative to making an educated guess about the benefit randomized controlled trials such as the NLST, but models can of adjuvant therapy, the study by Wang et al21 attempts to offer uniquely extend the time horizon and expand the population studied, Journal of Clinical Oncology, Vol 29, 2011 © 2011 by American Society of Clinical Oncology 1 Information downloaded from jco.ascopubs.org and provided by at Oregon Health & Science University on November 7, Copyright © 2011 American Society of Clinical Oncology. All rights reserved. 2011 from 137.53.32.65 Copyright 2011 by American Society of Clinical Oncology
2.
Rebecca A. Miksad evaluate
alternative screening strategies, and assess the relative value of practice, and health policy to ensure that the best decisions are made potential policy interventions. for patients. These unique abilities of computer models are particularly valu- able when policy decisions must be made on the basis of available data, AUTHOR’S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The author(s) indicated no potential conflicts of interest. including observational or single-arm studies, until more definitive RCT results are available and in situations in which funding, time, and REFERENCES patient populations limit answerable research questions.32 For exam- 1. Knudsen AB, McMahon PM, Gazelle GS: Use of modeling to evaluate the ple, a simulated control group for the single-arm Mayo lung cancer cost-effectiveness of cancer screening programs. J Clin Oncol 25:203-208, 2007 screening study with the LCPM allowed exploration of the contradic- 2. Weiser MR: Rectal cancer trials: No movement. J Clin Oncol 29:2746- 2748, 2011 tory results of two large clinical studies.33-37 In addition, the LCPM 3. Miksad RA: Pathologic complete response and toxicity results from the was able to assess 15-year survival estimates for three different screen- STAR-01 Trial evaluating the addition of oxaliplatin to neodjuvant chemoradiation ing strategies—a significantly longer time-line and a more complex for locally advanced rectal cancer. J Clin Oncol 29, 2011. http://jco.ascopubs.org/ content/29/20/2773/suppl/DC2 analysis than is typically possible in an RCT.20 4. LoRusso PM, Schnipper LE, Stewart DJ, et al: Translating clinical trials into Simulationmodelingalongsideclinicalresearchmayalsostrengthen meaningful outcomes. Clin Cancer Res 16:5951-5955, 2010 trial findings by allowing the exploration of areas of potential bias: 5. LoRusso PM, Anderson AB, Boerner SA, et al: Making the investigational concerns about the NSLT false-positive rate and potential for overdi- oncology pipeline more efficient and effective: Are we headed in the right direction? Clin Cancer Res 16:5956-5962, 2010 agnosis that were suggested by the 16-year results of the Mayo study 6. Schnipper LE, Meropol NJ, Brock DW: Value and cancer care: Toward an can be explicitly evaluated in a model.32 In addition, the flexibility of equitable future. Clin Cancer Res 16:6004-6008, 2010 the simulation models also allows evaluation of questions raised by the 7. Miksad RA, Schnipper L, Goldstein M: Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer NSLT study that are important to clinicians and policy makers but for translate into clinical significance and value? J Clin Oncol 25:4506-4507, 2007; which repeated, long-term clinical trials are not possible: the benefit author reply 4508 of screening in populations with lower or variable adherence, the effect 8. Butler D: Translational research: Crossing the valley of death. Nature of extending annual screening beyond 3 years, as well as the impact of 453:840-842, 2008 9. Booth CM: Evaluating patient-centered outcomes in the randomized screening on light smokers and genomic subgroups. On the societal controlled trial and beyond: Informing the future with lessons from the past. Clin level, an additional value of modeling is to generate novel hypotheses Cancer Res 16:5963-5971, 2010 and to identify research questions that merit clinical trial resources. 10. Rutter CM, Knudsen AB, Pandharipande PV: Computer disease simulation Although it is not a comprehensive microsimulation model like models: Integrating evidence for health policy. Acad Radiol 18:1077-1086, 2010 11. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al: Evaluating Test the LCPM, the model described by Wang et al21 moves gallbladder Strategies for Colorectal Cancer Screening: Age to Begin, Age to Stop, and cancer clinical care forward by offering evidence in favor of adjuvant Timing of Screening Intervals—A Decision Analysis of Colorectal Cancer Screen- chemoradiotherapy for some patients and by providing guidance for ing for the U.S. Preventive Surveillance Modeling Network (CISNET). Rockville, MD, Agency for Healthcare Research and Quality, 2009 gallbladder cancer research. For example, future studies can take ad- 12. Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, et al: Cost-effectiveness of vantage of model efficacy estimates to help guide clinical trial de- computed tomographic colonography screening for colorectal cancer in the sign, to identify subgroups (adjuvant chemoradiotherapy benefit medicare population. J Natl Cancer Inst 102:1238-1252, 2010 may be small for patients with node-negative disease), to help 13. Pandharipande PV, Choy G, del Carmen MG, et al: MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: refine target populations, and to highlight areas for additional Decision analysis to assess patient outcomes. AJR Am J Roentgenol 192:802- research (the interaction between extended lymphadenectomy and 814, 2009 adjuvant chemotherapy). Building from the results by Wang et al, 14. Pandharipande PV, Gervais DA, Hartman RI, et al: Renal mass biopsy to guide treatment decisions for small incidental renal tumors: A cost-effectiveness a microsimulation model calibrated to and validated with external analysis. Radiology 256:836-846, 2010 data sets may increase the robustness and precision of adjuvant che- 15. Ladapo JA, Jaffer FA, Hoffmann U, et al: Clinical outcomes and cost- moradiotherapy model predictions. effectiveness of coronary computed tomography angiography in the evaluation of The statistical aspects of the survival analysis model by Wang et patients with chest pain. J Am Coll Cardiol 54:2409-2422, 2009 16. Pandharipande PV, Harisinghani MG, Ozanne EM, et al: Staging MR al,21 the majority of which was originally reported in a technical jour- lymphangiography of the axilla for early breast cancer: Cost-effectiveness anal- nal, also merit discussion.38 Although the Cox proportional hazard ysis. AJR Am J Roentgenol 191:1308-1319, 2008 ratio model is commonly used in medicine, other survival analysis 17. McMahon PM, Kong CY, Johnson BE, et al: Estimating long-term effec- methods, such as the accelerated failure time log normal model used tiveness of lung cancer screening in the Mayo CT screening study. Radiology 248:278-287, 2008 by Wang et al, may more appropriately reflect the biology of some 18. Gazelle GS, Hunink MG, Kuntz KM, et al: Cost-effectiveness of hepatic cancer scenarios.39 For example, accelerated failure time models allow metastasectomy in patients with metastatic colorectal carcinoma: A state- the intervention effect to change over time, as is seen when the effec- transition Monte Carlo decision analysis. Ann Surg 237:544-555, 2003 19. Huang ES, Gazelle GS, Hur C: Consensus guidelines in the management of tiveness of chemotherapy decreases over time because of resistance. branch duct intraductal papillary mucinous neoplasm: A cost-effectiveness anal- Similar to findings in other cancers,40,41 Wang et al demonstrate the ysis. Dig Dis Sci 55:852-860, 2010 need for careful consideration of the best analytic method by docu- 20. McMahon PM, Kong CY, Weinstein MC, et al: Adopting helical CT menting performance variations for five gallbladder survival model screening for lung cancer: Potential health consequences during a 15-year period. Cancer 113:3440-3449, 2008 analysis approaches. The oncology community should expect rigor- 21. Wang SJ, Lemieux A, Kalpathy-Cramer J, et al: Nomogram for predicting ous consideration of the appropriate survival analysis methods in all the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin clinical trial and modeling research. As the application of cancer mod- Oncol doi: 10.1200/JCO.2010.33.8020 22. Macdonald OK, Crane CH: Palliative and postoperative radiotherapy in els expands, researchers, clinicians, and policy makers who under- biliary tract cancer. Surg Oncol Clin N Am 11:941-954, 2002 stand both the clinical research and computer modeling worlds are 23. Southwest Oncology Group: S0809 –Phase II: A Phase II Trial of Adjuvant needed to translate between model results, clinical trial design, clinical Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine 2 © 2011 by American Society of Clinical Oncology JOURNAL OF CLINICAL ONCOLOGY Information downloaded from jco.ascopubs.org and provided by at Oregon Health & Science University on November 7, Copyright © 2011 American Society of Clinical Oncology. All rights reserved. 2011 from 137.53.32.65
3.
Editorials and Radiotherapy in
Extrahepatic Cholangiocarcinoma [protocol abstract]. http:// 33. Henschke CI, Naidich DP, Yankelevitz DF, et al: Early lung cancer action swog.org/Visitors/ViewProtocolDetails.asp?ProtocolNumber S0809 project: Initial findings on repeat screenings. Cancer 92:153-159, 2001 24. Jarnagin WR, Ruo L, Little SA, et al: Patterns of initial disease recurrence 34. Swensen SJ, Jett JR, Hartman TE, et al: CT screening for lung cancer: after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implica- Five-year prospective experience. Radiology 235:259-265, 2005 tions for adjuvant therapeutic strategies. Cancer 98:1689-1700, 2003 35. Swensen SJ, Jett JR, Sloan JA, et al: Screening for lung cancer with 25. National Comprehensive Cancer Network: NCCN Guidelines: Hepatobiliary low-dose spiral computed tomography. Am J Respir Crit Care Med 165:508-513, Cancers, Version 2.2011. http://www.nccn.org/professionals/physician_gls/f_ 2002 guidelines.asp 36. International Early Lung Cancer Action Program Investigators, Henschke 26. Yu JB, Zelterman D, Decker RH, et al: Impact of immediate postoperative CI, Yankelevitz DF, et al: Survival of patients with stage I lung cancer detected on death on the estimation of a survival benefit from postoperative radiation therapy CT screening. N Engl J Med 355:1763-1771, 2006 for cancer of the gallbladder. J Clin Oncol 26:4523, 2008; author reply 4524-4526 37. Bach PB, Jett JR, Pastorino U, et al: Computed tomography screening and 27. Cleary SP, Tan JC, Law CH, et al: Treatment considerations for gallbladder lung cancer outcomes. JAMA 297:953-961, 2007 cancer should include extent of surgery. J Clin Oncol 26:4521-4522, 2008; author 38. Wang SJ, Kalpathy-Cramer J, Kim JS, et al: Parametric survival models for reply 4524-4526 predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer. AMIA 28. Arroyo GF, Lemoine G: Prediction model for adjuvant radiation therapy for Annu Symp Proc 2010:847-851, 2010 gallbladder cancer: Not ready to be used. J Clin Oncol 26:4522-4523, 2008; 39. Ahmed FE, Vos PW, Holbert D: Modeling survival in colon cancer: A author reply 4524-4526 methodological review. Mol Cancer 6:15, 2007 29. Wang SJ, Fuller CD, Kim JS, et al: Prediction model for estimating the 40. Anderson JR, Cain KC, Gelber RD, et al: Analysis and interpretation of the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol comparison of survival by treatment outcome variables in cancer clinical trials. 26:2112-2117, 2008 Cancer Treat Rep 69:1139-1146, 1985 30. Knight Cancer Institute of Oregon Health and Science University: Gallbladder 41. Smith LK, Lambert PC, Botha JL, et al: Providing more up-to-date esti- Cancer Adjuvant Therapy, 2011. http://skynet.ohsu.edu/nomograms/gallbladder/ mates of patient survival: A comparison of standard survival analysis with period 31. National Lunch Screening Trial Research Team, Aberle DR, Adams AM, et analysis using life-table methods and proportional hazards models. J Clin Epide- al: Reduced lung-cancer mortality with low-dose computed tomographic screen- miol 57:14-20, 2004 ing. N Engl J Med 365:395-409, 2010 32. Sox HC: Better evidence about screening for lung cancer. N Engl J Med DOI: 10.1200/JCO.2011.37.8604; published online ahead of print at Aug 365:455-457, 2011 www.jco.org on November 7, 2011 ■ ■ ■ Acknowledgment R.A.M. is supported by the National Cancer Institute Grant No. 1 K23 CA139005-01A1. www.jco.org © 2011 by American Society of Clinical Oncology 3 Information downloaded from jco.ascopubs.org and provided by at Oregon Health & Science University on November 7, Copyright © 2011 American Society of Clinical Oncology. All rights reserved. 2011 from 137.53.32.65
Baixar agora